NO20022739D0 - New therapeutic combinations of (S) -2- (benzylamino-methyl) - 2,3,8,9-tetrahydro-7H-1,4-dioxino [2,3-e] indol-8-one and neuroleptics for treatment or prevention of psychotic disorders - Google Patents

New therapeutic combinations of (S) -2- (benzylamino-methyl) - 2,3,8,9-tetrahydro-7H-1,4-dioxino [2,3-e] indol-8-one and neuroleptics for treatment or prevention of psychotic disorders

Info

Publication number
NO20022739D0
NO20022739D0 NO20022739A NO20022739A NO20022739D0 NO 20022739 D0 NO20022739 D0 NO 20022739D0 NO 20022739 A NO20022739 A NO 20022739A NO 20022739 A NO20022739 A NO 20022739A NO 20022739 D0 NO20022739 D0 NO 20022739D0
Authority
NO
Norway
Prior art keywords
prevention
treatment
dioxino
neuroleptics
benzylamino
Prior art date
Application number
NO20022739A
Other languages
Norwegian (no)
Other versions
NO20022739L (en
Inventor
Karen Lovell Marquis
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of NO20022739D0 publication Critical patent/NO20022739D0/en
Publication of NO20022739L publication Critical patent/NO20022739L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Therapeutic combinations useful in the treatment or prevention of psychotic disorders, to pharmaceutical compositions containing said combinations, and to their use in the treatment or prophylaxis of prevention disorders are provided.
NO20022739A 1999-12-10 2002-06-07 New therapeutic combinations of (S) -2- (benzylamino-methyl) -2,3,8,9-tetrahydro-7H-1,4-dioxino [2,3-e] indol-8-one and neuroleptics for treatment or prevention of psychotic disorders NO20022739L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45860799A 1999-12-10 1999-12-10
PCT/US2000/033060 WO2001041750A2 (en) 1999-12-10 2000-12-07 Combinations of (s)-2-(benzylamino-methyl)-2,3,8,9,-tetrahydro-7h-1,4-dioxino(2,3)-e indol-8-one and neuroleptics

Publications (2)

Publication Number Publication Date
NO20022739D0 true NO20022739D0 (en) 2002-06-07
NO20022739L NO20022739L (en) 2002-06-07

Family

ID=23821437

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022739A NO20022739L (en) 1999-12-10 2002-06-07 New therapeutic combinations of (S) -2- (benzylamino-methyl) -2,3,8,9-tetrahydro-7H-1,4-dioxino [2,3-e] indol-8-one and neuroleptics for treatment or prevention of psychotic disorders

Country Status (20)

Country Link
EP (1) EP1235570A2 (en)
JP (1) JP5557409B2 (en)
KR (1) KR100772854B1 (en)
CN (1) CN1230164C (en)
AR (1) AR026756A1 (en)
AU (1) AU784211B2 (en)
BR (1) BR0016168A (en)
CA (1) CA2396351C (en)
CZ (1) CZ20021880A3 (en)
EA (1) EA005002B1 (en)
HK (1) HK1045942A1 (en)
HU (1) HUP0203309A3 (en)
IL (2) IL149669A0 (en)
MX (1) MXPA02005649A (en)
NO (1) NO20022739L (en)
NZ (1) NZ519381A (en)
PL (1) PL355292A1 (en)
TW (1) TWI222864B (en)
WO (1) WO2001041750A2 (en)
ZA (1) ZA200205484B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050095292A1 (en) 2003-10-29 2005-05-05 Wyeth Sustained release pharmaceutical compositions
WO2006089053A2 (en) 2005-02-17 2006-08-24 Wyeth Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives
ES2430622T3 (en) * 2008-02-13 2013-11-21 Targacept, Inc. Combination of alpha 7 nicotinic and antipsychotic agonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2987484B2 (en) * 1995-03-16 1999-12-06 大塚製薬 株式会社 Method for producing carbostyril derivative
US5756532A (en) 1995-11-06 1998-05-26 American Home Products Corporation Aminomethyl-2 3 8 9-tetrahydro-7H-1 4-dioxino 2 3-E!-indol-8-ones and derivatives
GB9627005D0 (en) * 1996-12-27 1997-02-12 Knoll Ag Therapeutic agents

Also Published As

Publication number Publication date
PL355292A1 (en) 2004-04-05
JP2003516350A (en) 2003-05-13
HK1045942A1 (en) 2002-12-20
CN1230164C (en) 2005-12-07
CN1409633A (en) 2003-04-09
EA005002B1 (en) 2004-10-28
CA2396351A1 (en) 2001-06-14
ZA200205484B (en) 2003-12-31
EP1235570A2 (en) 2002-09-04
KR100772854B1 (en) 2007-11-02
BR0016168A (en) 2002-08-20
NO20022739L (en) 2002-06-07
TWI222864B (en) 2004-11-01
HUP0203309A2 (en) 2003-01-28
WO2001041750A2 (en) 2001-06-14
NZ519381A (en) 2004-04-30
EA200200656A1 (en) 2002-12-26
JP5557409B2 (en) 2014-07-23
CZ20021880A3 (en) 2002-08-14
HUP0203309A3 (en) 2004-12-28
AU784211B2 (en) 2006-02-23
CA2396351C (en) 2009-11-10
MXPA02005649A (en) 2004-09-10
AR026756A1 (en) 2003-02-26
IL149669A0 (en) 2002-11-10
AU1949001A (en) 2001-06-18
IL149669A (en) 2006-06-11
KR20030016207A (en) 2003-02-26
WO2001041750A3 (en) 2002-02-14

Similar Documents

Publication Publication Date Title
EE200300033A (en) Cyclopentanoindoles, their use in the preparation of a medicament, and the pharmaceutical composition containing them
TWI265808B (en) Valdecoxib compositions
IL154888A (en) Non-aqueous pharmaceutical gel composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid and its use in the manufacture of a medicament for treatment of psoriasis
EP1259240B8 (en) Agents, such as nicotinamide or cadpr for the treatment of skin disorders
ATE399553T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING DEXTROMETHORPHAN AND QUINIDENE FOR THE TREATMENT OF NEUROLOGICAL DISEASES
NO306779B1 (en) Naphthalamides, their use and pharmaceutical preparation
AU2001266152A1 (en) Novel substituted nitrocatechols, their use in the treatment of some central andperipheral nervous system disorders and pharmaceutical compositions containing them
DE69919179D1 (en) SUBSTITUTED GAMMA-PHENYL-DELTA-LACTONE AND THEIR ANALOGS, AND THEIR USE
ES2173887T3 (en) NEW PHARMACEUTICAL USES OF THE KRILL ENZYMES.
TW200510367A (en) Novel lapachone compounds, their preparation, and the use thereof
IT1264530B (en) USE OF POLYSACCHARIDES IN ATROPHIC DEGENERATIVE NEUROPATHIES
SE9802208D0 (en) Novel compounds
HUP9602498A2 (en) Pharmaceutical compositions of antimicrobial activity
CA2284551A1 (en) New therapeutic combinations of mirtazapine and antipsychotic agents, for the treatment or prophylaxis of psychotic disorders
MXPA04001328A (en) Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof.
DE69939075D1 (en) Pharmaceutical composition for the prevention and treatment of diseases associated with cell diseases of the fundus
SE0001916D0 (en) Novel formulation
SE9802209D0 (en) Novel compounds
NO20022739D0 (en) New therapeutic combinations of (S) -2- (benzylamino-methyl) - 2,3,8,9-tetrahydro-7H-1,4-dioxino [2,3-e] indol-8-one and neuroleptics for treatment or prevention of psychotic disorders
MX9805065A (en) Novel bi-aromatic dibenzofuran derivatives and their use in human and veterinary medicine and in cosmetics.
TR200200278T2 (en) Calcilitic compositions
JO2199B1 (en) Substituted pyrroles
TR199901385T2 (en) Piperidin t�revleri.
WO2002076930A3 (en) Substituted diarylureas as stimulators for fas-mediated apoptosis
AU3992897A (en) Use of sulbutiamine to obtain pharmaceutical compositions useful in the treatment of certain psychomotor and psycho-intellectual disorders

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application